Tecsys Inc. (TSE:TCS - Get Free Report) has received a consensus rating of "Buy" from the six analysts that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and two have issued a strong buy rating on the company. The average 12-month target price among brokers that have covered the stock in the last year is C$38.70.
Several analysts have recently commented on the stock. TD set a C$39.00 target price on shares of Tecsys and gave the company a "buy" rating in a report on Wednesday, July 8th. TD Securities raised Tecsys to a "strong-buy" rating in a research note on Thursday, July 9th. National Bank Financial upgraded Tecsys from a "sector perform" rating to an "outperform" rating and raised their price target for the company from C$40.00 to C$46.00 in a research report on Wednesday, May 27th. Finally, Canaccord Genuity Group raised Tecsys to a "strong-buy" rating in a research note on Thursday, August 6th.
Check Out Our Latest Stock Report on TCS
Insider Buying and Selling at Tecsys
In related news, Director David Brereton sold 1,700 shares of the business's stock in a transaction that occurred on Friday, July 17th. The stock was sold at an average price of C$33.00, for a total value of C$56,100.00. Following the completion of the sale, the director owned 714,572 shares in the company, valued at C$23,580,876. The trade was a 0.24% decrease in their position. Over the last 90 days, insiders sold 4,700 shares of company stock worth $161,819. Company insiders own 17.05% of the company's stock.
Tecsys Price Performance
TCS stock opened at C$32.63 on Thursday. The company has a debt-to-equity ratio of 8.49, a quick ratio of 1.40 and a current ratio of 1.12. The business has a 50-day simple moving average of C$34.19 and a two-hundred day simple moving average of C$31.45. The company has a market capitalization of C$470.43 million, a P/E ratio of 120.85 and a beta of 0.85. Tecsys has a 52-week low of C$22.51 and a 52-week high of C$38.00.
Tecsys (TSE:TCS - Get Free Report) last posted its earnings results on Monday, June 29th. The company reported C($0.02) earnings per share for the quarter. The company had revenue of C$50.05 million during the quarter. Tecsys had a net margin of 2.09% and a return on equity of 5.99%. Research analysts expect that Tecsys will post 0.4600739 EPS for the current fiscal year.
Tecsys Company Profile
(
Get Free Report)
Tecsys is trusted by mission-critical organizations in healthcare and distribution to build resilient, efficient and secure supply chains. A global provider of cloud-based, AI-driven software with deep domain expertise, Tecsys delivers real-time operational visibility and execution across critical workflows when performance and reliability matter most. Tecsys is publicly traded on the Toronto Stock Exchange (TCS). For more information, visit www.tecsys.com.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Tecsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tecsys wasn't on the list.
While Tecsys currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.